{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:13:49Z","timestamp":1773249229841,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ygyno.2008.06.029","type":"journal-article","created":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T08:19:31Z","timestamp":1216801171000},"page":"S11-S17","source":"Crossref","is-referenced-by-count":45,"special_numbering":"S1","title":["Impact of vaccination with Cervarix\u2122 on subsequent HPV-16\/18 infection and cervical disease in women 15\u201325\u00a0years of age"],"prefix":"10.1016","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct001122681","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00120848","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00122681","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Diane M.","family":"Harper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2008.06.029_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer.","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ygyno.2008.06.029_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2008.06.029_bib3","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.vaccine.2006.05.026","article-title":"Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases","volume":"24","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ygyno.2008.06.029_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.11222","article-title":"Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study","volume":"106","author":"Dalstein","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"7364","key":"10.1016\/j.ygyno.2008.06.029_bib5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study","volume":"325","author":"Kjaer","year":"2002","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ygyno.2008.06.029_bib6","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jnci\/91.11.954","article-title":"Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions","volume":"91","author":"Liaw","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"9172","key":"10.1016\/j.ygyno.2008.06.029_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(98)12490-X","article-title":"Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study","volume":"354","author":"Nobbenhuis","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ygyno.2008.06.029_bib8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5858\/2003-127-946-FTDFTA","article-title":"Findings to date from the ASCUS-LSIL Triage Study (ALTS)","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"24","key":"10.1016\/j.ygyno.2008.06.029_bib9","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","article-title":"Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia","volume":"286","author":"Schlecht","year":"2001","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ygyno.2008.06.029_bib10","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199911253412201","article-title":"Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer","volume":"341","author":"Wallin","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ygyno.2008.06.029_bib11","first-page":"6027","article-title":"A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ","volume":"60","author":"Ylitalo","year":"2000","journal-title":"Cancer Res."},{"issue":"9271","key":"10.1016\/j.ygyno.2008.06.029_bib12","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ygyno.2008.06.029_bib13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.","volume":"97","author":"Khan","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ygyno.2008.06.029_bib14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ygyno.2008.06.029_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.ygyno.2008.06.029_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.vaccine.2004.07.046","article-title":"Efficacy and other milestones for human papillomavirus vaccine introduction","volume":"23","author":"Pagliusi","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ygyno.2008.06.029_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.bjc.6603575","article-title":"Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland","volume":"96","author":"French","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"9447","key":"10.1016\/j.ygyno.2008.06.029_bib18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"issue":"9518","key":"10.1016\/j.ygyno.2008.06.029_bib19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5\u00a0years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"9580","key":"10.1016\/j.ygyno.2008.06.029_bib20","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2008.06.029_bib21","unstructured":"Gall S, Teixeira J, Wheeler C, Naud P, Harper D, Franco E, et al. Substantial impact on precancerous lesions and HPV infections through 5.5\u00a0years in women vaccinated with the HPV-16\/18 L1 VLP AS04 candidate vaccine. American Association for Cancer Research Annual Meeting, Los Angeles, CA, USA, Apr 14\u201318; 2007."},{"issue":"5","key":"10.1016\/j.ygyno.2008.06.029_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsague","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ygyno.2008.06.029_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0301-2115(01)00524-3","article-title":"Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix","volume":"101","author":"Erzen","year":"2002","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"10.1016\/j.ygyno.2008.06.029_bib24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ijc.20678","article-title":"Cervical cancer in the Netherlands 1989\u20131998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women","volume":"113","author":"Bulk","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2008.06.029_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2008.06.029_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bpobgyn.2005.02.002","article-title":"Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix","volume":"19","author":"Tjalma","year":"2005","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.06.029_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/gyno.1997.4779","article-title":"Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia","volume":"66","author":"Umezaki","year":"1997","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2008.06.029_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D","article-title":"International trends in incidence of cervical cancer: II. Squamous-cell carcinoma","volume":"86","author":"Vizcaino","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2008.06.029_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U","article-title":"International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas","volume":"75","author":"Vizcaino","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2008.06.029_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF02893378","article-title":"Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma","volume":"11","author":"Cambruzzi","year":"2005","journal-title":"Pathol. Oncol. Res."},{"issue":"9509","key":"10.1016\/j.ygyno.2008.06.029_bib31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis.","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ygyno.2008.06.029_bib32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808005003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808005003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T18:06:56Z","timestamp":1631556416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808005003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0090825808005003"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.06.029","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}